American Study Shockingly Discovers That Copper Fuels Kidney Cancer Progression and Spread!

Medical News: Copper's Role in Advancing Kidney Cancer Offers New Insights
Researchers at the University of Cincinnati Cancer Center-USA have uncovered how copper, a crucial trace element, promotes the progression of clear cell renal cell carcinoma (ccRCC) - the most common form of kidney cancer. While copper is essential for human life, providing energy for cellular functions and allowing us to thrive in oxygen-rich environments, excessive copper levels have been linked to cancer's ability to grow and spread. This Medical News dives into the findings of this innovative study, offering a detailed look at how copper accumulation could serve as a biomarker and potential therapeutic target for kidney cancer patients.


American Study Shockingly Discovers That Copper Fuels Kidney Cancer Progression and Spread

The Impact of Copper on Kidney Cancer Progression
Dr. Maria Czyzyk-Krzeska, a lead researcher from the University of Cincinnati’s Department of Cancer Biology, explains that higher levels of copper are associated with more advanced stages of ccRCC. According to Czyzyk-Krzeska, the cancer cells progressively gather more copper as they advance, from early stages to metastatic disease. Copper, in turn, helps the cells produce more of an enzyme that fuels their energy and growth, giving them a significant survival advantage.
The team found that copper’s influence on kidney cancer cells goes beyond merely providing energy. It plays a critical role in the creation of glutathione, a molecule that shields the cells from toxins and reduces the harmful effects of copper itself. This combination of copper and glutathione makes the cells more resilient and capable of adapting to the stressors that would otherwise threaten their survival.
 
Metabolic “Hot Spots” and Cancer Growth
Using advanced tools like single-cell RNA sequencing and spatial transcriptomics, the researchers identified areas within the tumors where copper-driven metabolic activity was most intense. These “hot spots” of copper-dependent energy production were often located near other tumor cells that displayed signs of rapid growth. Dr. Czyzyk-Krzeska noted that these hot spots suggest a connection between metabolically active cells and proliferative cells, hinting that the former may support the growth and survival of the latter.
 
This discovery sheds light on a previously unknown metabolic partnership between different cells within ccRCC tumors, potentially explaining why the disease is challenging to treat. The presence of copper boosts the cancer cells' ability to produce energy and detoxify themselves, allowing them to overcome environmental stressors and thrive in the hostile environment of a growing tumor.
 
Potential Environmental Factors and Copper Accumulation
The study also raises questions about the sources of copper accumulation in kidney cancer cells. The researchers speculate that environmental factors, such as tobacco smoke, e-cigarette usage, or exposure t o wildfire smoke, could contribute to higher copper levels in tumors. Veterans and individuals exposed to copper through ammunition or shooting ranges might be at a greater risk for ccRCC.
 
Although these factors are plausible contributors, researchers caution that cancer cells might also have intrinsic mechanisms that actively take in copper.
 
Understanding why and how cancer cells accumulate copper could pave the way for developing strategies to limit this metal’s availability to cancer cells, slowing the disease's progression.
 
It was also warned that copper supplementation can also contribute to the accumulation of copper in kidney cells.
 
Exploring New Treatment Options Based on Copper Dependence
The study’s findings open up new possibilities for treating ccRCC by targeting copper and its associated metabolic pathways. Dr. Czyzyk-Krzeska emphasizes that while the research is still in the experimental phase, identifying the cancer cells’ reliance on copper may reveal vulnerabilities that treatments could exploit. One potential approach is to develop combination therapies targeting both the metabolic and proliferative cells, potentially increasing the treatment’s effectiveness.
 
Moreover, copper levels in patients could serve as a biomarker to predict how aggressive the cancer is or how likely it is to recur post-surgery. Such a biomarker would be particularly valuable, given that approximately 30-50% of ccRCC patients experience a relapse within five years after surgery.
 
How Copper Shapes Cancer Cell Behavior
The study’s findings reveal that copper functions as a cofactor for cytochrome c oxidase (CuCOX), an enzyme essential for cellular respiration. Advanced ccRCC tumors accumulate copper, directing it to CuCOX, which enhances the cells’ energy production. The study demonstrated that elevated copper levels stimulate the creation of CuCOX, providing the cancer cells with bioenergetic and biosynthetic advantages, ultimately promoting tumor growth.
 
In addition to supporting energy production, copper-dependent glutathione production enables cancer cells to detoxify themselves from the harmful effects of copper. This detoxification process protects the cells, allowing them to maintain their high metabolic activity without succumbing to the toxic effects of copper and hydrogen peroxide.
 
Future Directions and Therapeutic Possibilities
The study’s findings highlight a key vulnerability in ccRCC’s metabolic reliance on copper. Moving forward, Czyzyk-Krzeska’s team aims to investigate why ccRCC cells accumulate copper and explore whether certain treatments could inhibit copper's impact on tumor growth. One potential approach is to reduce copper availability, which could starve the cancer cells of the resources they need to grow.
 
Additionally, copper levels in blood and tumor tissue might serve as reliable markers to predict cancer progression and response to treatment. If validated, copper levels could help doctors identify patients at higher risk of recurrence, allowing for more personalized treatment plans.
 
Conclusion: A New Chapter in Kidney Cancer Research
This research not only identifies copper as a driver of kidney cancer progression but also suggests that targeting copper-related metabolic pathways could open up new avenues for treatment. The insights gained from this study could revolutionize ccRCC treatment, allowing doctors to target the disease at its metabolic core. Furthermore, copper’s role as a biomarker could provide essential information about cancer severity and recurrence risk, paving the way for more effective and personalized therapeutic approaches.
 
For now, the research team is focused on uncovering the exact mechanisms through which copper accumulates in ccRCC tumors and exploring how these pathways could be blocked. Their ongoing research represents a promising step toward improving outcomes for kidney cancer patients and illustrates the profound impact of team science on cancer research.
 
The study findings were published in the peer-reviewed journal: Cancer Discovery.
https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-24-0187/749588/Copper-drives-remodeling-of-metabolic-state-and
 
For the latest Cancer News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/breaking-news-gene-study-reveals-how-covid-19-mrna-vaccine-leads-to-high-risk-of-iga-nephropathy-eventual-kidney-failure-and-possible-cancers
 
https://www.thailandmedical.news/news/new-protocol-for-advanced-kidney-cancer-involving-drug-combo-of-avelumab-and-axitinib